Non-alcoholic fatty liver disease is not associated with vitamin D deficiency in essential hypertension

High Blood Pressure and Cardiovascular Prevention

Volumn 20, Issue 1, 2013, Pages 33-37

  Catena, Cristiana ^a   Cosma, Chiara ^b   Camozzi, Valentina ^b   Plebani, Mario ^b   Ermani, Mario ^b   Sechi, Leonardo A ^a   Fallo, Francesco ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Essential hypertension; NAFLD; Vitamin D

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; GLUCOSE; INSULIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; VITAMIN D DEFICIENCY;

ADIPONECTIN; ADULT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; HYPERTENSION; INSULIN; ITALY; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84879334654     PISSN: 11209879     EISSN: 11791985     Source Type: Journal    
DOI: 10.1007/s40292-013-0010-7     Document Type: Article

References (20)

1. Angulo P. GI epidemiology: non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2007;25:883-9.
2. Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:27-38.
3. Fallo F, Dalla Pozza A, Sonino N, Lupia M, Tona F, Federspil G, Ermani M, et al. Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. Nutr Metab Cardiovasc Disc. 2009;19:646-53.
4. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363:1341-50.
5. Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, et al. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011;9:85.
6. Zúñiga S, Firrincieli D, Housset C, Chignard N. Vitamin D and the vitamin D receptor in liver pathophysiology. Clin Res Hepatol Gastroenterol. 2011;35:295-302.
7. Kitson MT, Roberts SK. D-Livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol. 2012;57:897-909.
8. Rosen CJ. Clinical practice. Vitamin D insufficiency. N Engl J Med. 2011;364:248-54.
9. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxyvitamin D is predictive of future glycemic status and insulin resistance: the Medical Research council Ely Prospective Study 1990-2000. Diabetes. 2008;57:2619-25.
10. Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, Booth SL, et al. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistance phenotype in nondiabetic adults. J Nutr. 2009;139:329-34.
11. Pilz S, Tomaschitz A, Ritz E, Pleber TR. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol. 2009;6:621-30.
12. Muldowney S, Kiely M. Vitamin D and cardiometabolic health: a review of the evidence. Nutr Res Rev. 2011;1:1-20.
13. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germanò G, et al. ESH-ESC Task Force on the Management of Arterial Hypertension 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-87.
14. Fallo F, Dalla Pozza A, Sonino N, Federspil G, Ermani M, Baroselli S, et al. Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients. J Hypertens. 2008;26:2191-7.
15. Fallo F, Catena C, Camozzi V, Luisetto G, Cosma C, Plebani M, et al. Low serum 25-hydroxyvitamin D levels are associated with left ventricular hypertrophy in essential hypertension. Nutr Metab Cardiovasc Dis. 2012;22:871-6.
16. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and cell dysfunction. Am J Clin Nutr. 2004;79:820-5.
17. Katz K, Brar PC, Parekh N, Liu YH, Weitzman M. Suspected nonalcoholic fatty liver disease is not associated with vitamin D status in adolescents after adjustment for obesity. J Obes. 2010; Article ID 496829.
18. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2007;17:517-24.
19. Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52:1836-46.
20. Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB. Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res. 2004;24:459-64.